Erythromycin Prices Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data Report 2026 Edition
Erythromycin Price Trend, Index and Forecast
Track the latest insights on erythromycin price trend and forecast with detailed analysis of regional fluctuations and market dynamics across North America, Latin America, Central Europe, Western Europe, Eastern Europe, Middle East, North Africa, West Africa, Central and Southern Africa, Central Asia, Southeast Asia, South Asia, East Asia, and Oceania.
Erythromycin Prices Outlook Q1 2026
- USA: USD 183389/MT
- China: USD 143030/MT
- Germany: USD 179795/MT
- India: USD 121619/MT
- Brazil: USD 204341/MT
Erythromycin Price Chart
Get real-time access to monthly/quarterly/yearly prices Request Sample
During the first quarter of 2026, the erythromycin prices in the USA reached 183389 USD/MT in March. Prices moved upward as pharmaceutical buyers maintained steady procurement for antibiotic formulations. Demand from human healthcare and veterinary medicine supported the market, while supply remained controlled due to strict quality checks and regulated production standards. Importers faced firm replacement costs, and suppliers avoided aggressive discounting because of stable downstream offtake.
During the first quarter of 2026, the erythromycin prices in China reached 143030 USD/MT in March. Prices increased as domestic antibiotic manufacturing activity improved and exporters received steady inquiries from overseas formulation companies. Producers managed operating rates carefully to avoid oversupply, which helped maintain price strength. Demand from pharmaceutical intermediates and finished dosage manufacturers remained healthy, supporting spot market sentiment.
During the first quarter of 2026, the erythromycin prices in Germany reached 179795 USD/MT in March. Prices declined as buyers adopted cautious procurement amid sufficient inventories across pharmaceutical distribution channels. Demand from formulation units remained moderate, but limited urgency for fresh purchases weighed on market sentiment. Import availability improved, giving buyers stronger negotiation power.
During the first quarter of 2026, the erythromycin prices in India reached 121619 USD/MT in March. Prices rose as domestic demand from pharmaceutical formulation manufacturers improved. Procurement activity strengthened with steady orders from antibiotic producers and exporters. Supply remained balanced, as manufacturers controlled output according to confirmed demand. Raw material and processing costs supported firmer offers, while sellers resisted discounts due to stable offtake.
During the first quarter of 2026, the erythromycin prices in Brazil reached 204341 USD/MT in March. Prices increased as import dependent supply conditions supported firm market sentiment. Pharmaceutical distributors and formulation companies maintained active procurement to secure material availability. Higher replacement costs and limited supplier flexibility added upward pressure. Domestic buyers faced firm offers from overseas producers, while currency related purchasing caution influenced contract negotiations.
Erythromycin Prices Outlook Q2 2025
- USA: USD 169616/MT
- China: USD 145847/MT
- Germany: USD 179214/MT
- India: USD 116918/MT
- Brazil: USD 188248/MT
During the second quarter of 2025, the erythromycin prices in the USA reached 169616 USD/MT in June. In the USA, erythromycin prices were influenced by steady demand from hospitals, clinics, and pharmaceutical distributors. Domestic production costs were shaped by feedstock availability and high energy and labor expenses. Imports from Asia supplemented supply, with landed costs impacted by shipping rates, port handling, and customs procedures. Regulatory compliance with Food and Drug Administration requirements for antibiotics added certification and testing expenses. Distribution through extensive healthcare networks, including warehousing and trucking, further contributed to overall procurement costs.
During the second quarter of 2025, erythromycin prices in China reached 145847 USD/MT in June. In China, erythromycin prices were driven by strong demand from domestic healthcare facilities and pharmaceutical manufacturers. Production economics were shaped by the availability of fermentation feedstocks, energy tariffs, and local labor costs. Export commitments to North America and Europe influenced domestic allocation, while logistics costs from inland transport and port congestion added further expenses. Environmental regulations on pharmaceutical production facilities increased compliance costs, while currency fluctuations against the US dollar influenced export competitiveness.
During the second quarter of 2025, the erythromycin prices in Germany reached 179214 USD/MT in June. In Germany, erythromycin prices were influenced by demand from the healthcare and pharmaceutical sectors. Supply was supported by both domestic production and imports, with freight charges, customs duties, and port handling shaping landed costs. Production costs were elevated due to high energy tariffs and labor expenses, while strict European Union pharmaceutical regulations required extensive certification and testing. Distribution expenses, including warehousing and trucking, added further costs, particularly for nationwide distribution to hospitals and pharmacies.
During the second quarter of 2025, the erythromycin prices in India reached 116918 USD/MT in June. In India, erythromycin prices were shaped by strong demand from hospitals, clinics, and generic drug manufacturers. Production costs were influenced by the availability of fermentation feedstocks, energy tariffs, and domestic labor conditions. Export activity to Europe, North America, and Africa impacted domestic supply. Logistics inefficiencies, including trucking delays and fuel costs, contributed to distribution expenses. Compliance with Good Manufacturing Practices and international pharmaceutical certifications added operational costs for manufacturers serving both local and global markets.
During the second quarter of 2025, the erythromycin prices in Brazil reached 188248 USD/MT in June. In Brazil, erythromycin prices were guided by demand from public and private healthcare providers. Heavy reliance on imports made costs sensitive to global shipping charges, port inefficiencies, and customs regulations. Currency volatility of the Brazilian real against the US dollar strongly impacted landed costs. Domestic distribution challenges, including long-haul trucking and infrastructure limitations, added to supply chain expenses. Regulatory compliance with national health agency standards further increased certification and testing costs for both importers and local distributors.
Regional Coverage
The report provides a detailed analysis of the market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of FOB and CIF prices, as well as the key factors influencing erythromycin prices.
Europe Erythromycin Price Trend
Q1 2026:
The erythromycin price index in Europe showed a bearish movement with price pressure visible in major importing markets. Germany recorded a decline as buyers maintained adequate inventories and delayed fresh procurement. Pharmaceutical manufacturers focused on cost control, which reduced spot market urgency. Import availability from Asian suppliers remained steady, giving European buyers stronger bargaining power. Demand from antibiotic formulations continued, but it was not strong enough to lift prices across the region. Regulatory quality requirements kept procurement selective, favoring approved suppliers. Overall, Europe experienced softer sentiment due to cautious buying, stable supply, and limited restocking pressure.
Q2 2025:
As per the erythromycin price index, European erythromycin prices were shaped by demand from the healthcare and pharmaceutical manufacturing sectors. Supply relied on both domestic production and imports from Asia, with landed costs impacted by shipping rates, port handling, and customs procedures. Production economics within the region were influenced by high energy tariffs and labor costs. Strict European Union pharmaceutical regulations required rigorous testing, certification, and traceability, adding compliance-related expenses. Inland logistics, including trucking and warehousing, further contributed to distribution costs across key markets.
This analysis can be extended to include detailed erythromycin price information for a comprehensive list of countries.
| Region | Countries Covered |
|---|---|
| Europe | Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal, and Greece, among other European countries. |
North America Erythromycin Price Trend
Q1 2026:
The erythromycin price index in North America strengthened, supported by firm pharmaceutical demand and controlled availability. The USA market moved upward as formulation manufacturers maintained regular procurement for antibiotic production. Buyers focused on reliable sourcing due to strict quality standards and supply chain planning needs. Suppliers kept offers firm as production and import replacement costs remained supportive. Veterinary and healthcare applications added steady downstream consumption. Inventory levels were managed carefully, preventing oversupply.
Q2 2025:
As per the erythromycin price index, in North America, erythromycin prices were driven by demand from hospitals, clinics, and pharmaceutical distributors. Domestic production was supplemented by imports, particularly from Asia, with freight charges, customs documentation, and port operations influencing procurement. Feedstock costs for fermentation-based production shaped domestic manufacturing economics, while compliance with strict Food and Drug Administration standards added testing and certification expenses. Inland distribution through extensive healthcare networks, including warehousing and long-haul trucking, further increased overall supply chain costs across the region.
Specific erythromycin historical data within the United States and Canada can also be provided.
| Region | Countries Covered |
|---|---|
| North America | United States and Canada |
Middle East and Africa Erythromycin Price Trend
Q1 2026:
According to the erythromycin price chart, supply chain disruptions, seasonal variations in demand, and geopolitical pressures were the main causes of the price fluctuations in the Middle East and Africa.
Q2 2025:
As per the erythromycin price chart, the prices in the Middle East and Africa fluctuated due to a complex interplay of factors, primarily driven by supply chain disruptions, seasonal demand shifts, and geopolitical influences. A tight supply from refineries, exacerbated by maintenance rounds and unplanned outages, put pressure on prices. Simultaneously, demand from the agrochemical sector during the planting season contributed to price changes.
In addition to region-wise data, information on erythromycin prices for countries can also be provided.
| Region | Countries Covered |
|---|---|
| Middle East & Africa | Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco, among other Middle Eastern and African countries. |
Asia Pacific Erythromycin Price Trend
Q1 2026:
In Asia Pacific, erythromycin prices showed bullish movement. China and India recorded increases due to stronger pharmaceutical offtake and steady export inquiries. Producers managed output according to confirmed demand, which limited oversupply risk. Regional buyers continued procurement for antibiotic formulations, animal health products, and export linked dosage manufacturing. South and East Asian markets benefited from stable manufacturing activity and balanced inventory levels.
Q2 2025:
In Asia Pacific, erythromycin prices were influenced by strong demand from healthcare systems and generic drug manufacturers, with China and India playing major roles in production. Costs were shaped by feedstock availability for fermentation processes, energy tariffs, and labor conditions in pharmaceutical hubs. Export commitments to Europe and North America affected domestic allocation. Logistics expenses, including inland transportation and port congestion, further influenced supply chain economics. Regulatory compliance with international Good Manufacturing Practices and export certifications added operational costs for manufacturers.
This erythromycin price analysis can be expanded to include a comprehensive list of countries within the region.
| Region | Countries Covered |
|---|---|
| Asia Pacific | China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries. |
Latin America Erythromycin Price Trend
Q1 2026:
In Latin America, erythromycin prices strengthened, led by import dependent markets. Brazil recorded upward movement as buyers secured material from overseas suppliers amid firm replacement costs. Pharmaceutical distributors maintained procurement to support antibiotic demand from healthcare and veterinary sectors. Limited domestic production increased dependence on international supply, which kept sellers in a stronger position. Buyers showed caution but continued purchasing due to medicine availability needs.
Q2 2025:
In Latin America, particularly Brazil, erythromycin prices were guided by demand from public and private healthcare providers. Limited domestic production capacity increased reliance on imports, making costs sensitive to international shipping charges, port inefficiencies, and customs regulations. Currency volatility of the Brazilian real against the US dollar significantly shaped procurement expenses. Domestic logistics challenges, including long-haul trucking and infrastructure constraints, added further costs to distribution. Compliance with regulatory requirements set by national health authorities contributed to testing and certification expenses across the market.
This comprehensive review can be extended to include specific countries within the region.
| Region | Countries Covered |
|---|---|
| Latin America | Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru, among other Latin American countries. |
Erythromycin Pricing Report, Market Analysis, and News
IMARC's latest publication, “Erythromycin Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2026 Edition,” presents a detailed examination of the erythromycin market, providing insights into both global and regional trends that are shaping prices. This report delves into the spot price of erythromycin at major ports and analyzes the composition of prices, including FOB and CIF terms. It also presents detailed erythromycin prices trend analysis by region, covering North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The factors affecting erythromycin pricing, such as the dynamics of supply and demand, geopolitical influences, and sector specific developments, are thoroughly explored. This comprehensive report helps stakeholders stay informed with the latest market news, regulatory updates, and technological progress, facilitating informed strategic decision-making and forecasting.
Erythromycin Industry Analysis
The global erythromycin market size reached USD 19.5 Billion in 2025. By 2034, IMARC Group expects the market to reach USD 31.0 Billion, at a projected CAGR of 5.12% during 2026-2034. The market is primarily driven by the rising demand for flexible packaging, increasing use in automotive lightweight materials, and expanding applications in adhesives, sealants, and hygiene products.
Latest News and Developments:
- March 2026: Researchers developed a chemical method to modify common macrolide antibiotics, including erythromycin A, clarithromycin, and azithromycin, to help fight drug resistant bacteria. The study, published in ACS Central Science, uses a new azaadamantyl oxoammonium precatalyst to selectively oxidize hard to reach alcohol groups on antibiotic molecules. These changes helped the drugs bypass bacterial resistance mechanisms and showed activity against resistant strains, including MRSA, supporting future development of stronger treatments for infections that no longer respond to existing antibiotics.
Product Description
Erythromycin is a macrolide antibiotic produced through fermentation using strains of Saccharopolyspora erythraea. Commercial erythromycin mainly contains erythromycin A, along with related compounds in smaller amounts depending on the grade and purification process. It is generally available as a white to off white crystalline powder and is used in various salt and ester forms to improve stability, absorption, and formulation performance. Erythromycin works by binding to the 50S ribosomal subunit and inhibiting bacterial protein synthesis. It is mainly effective against gram positive bacteria and some gram negative bacteria. It is widely used in tablets, capsules, suspensions, topical preparations, ophthalmic products, and veterinary medicines. Its industrial relevance is linked to pharmaceutical manufacturing, antibiotic formulations, and regulated healthcare supply chains.
Report Coverage
| Key Attributes | Details |
|---|---|
| Product Name | Erythromycin |
| Report Features | Exploration of Historical Trends and Market Outlook, Industry Demand, Industry Supply, Gap Analysis, Challenges, Erythromycin Price Analysis, and Segment-Wise Assessment. |
| Currency/Units | US$ (Data can also be provided in local currency) or Metric Tons |
| Region/Countries Covered | The current coverage includes analysis at the global and regional levels only. Based on your requirements, we can also customize the report and provide specific information for the following countries: Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece North America: United States and Canada Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco The list of countries presented is not exhaustive. Information on additional countries can be provided if required by the client. |
| Information Covered for Key Suppliers |
|
| Customization Scope | The report can be customized as per the requirements of the customer |
| Report Price and Purchase Option |
Plan A: Monthly Updates - Annual Subscription
Plan B: Quarterly Updates - Annual Subscription
Plan C: Biannually Updates - Annual Subscription
|
| Post-Sale Analyst Support | 360-degree analyst support after report delivery |
| Delivery Format | PDF and Excel through email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Benefits for Stakeholders:
- IMARC’s report presents a detailed analysis of erythromycin pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
- The study examines factors affecting erythromycin price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
- The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
- IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The erythromycin price charts ensure our clients remain at the forefront of the industry.
Need more help?
- Speak to our experienced analysts for insights on the current market scenarios.
- Include additional segments and countries to customize the report as per your requirement.
- Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
- For further assistance, please connect with our analysts.
Request Customization
Inquire Before Buying
Speak to an Analyst
Request Brochure
Benefits of Customization
- Personalize this research
- Triangulate with your data
- Get data as per your format and definition
- Gain a deeper dive into a specific application, geography, customer, or competitor
- Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-201-971-6302
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-714-6104
Email: [email protected]
Client Testimonials
.webp)
.webp){kind=logo}
Why Choose Us
IMARC offers trustworthy, data-centric insights into commodity pricing and evolving market trends, enabling businesses to make well-informed decisions in areas such as procurement, strategic planning, and investments. With in-depth knowledge spanning more than 1000 commodities and a vast global presence in over 150 countries, we provide tailored, actionable intelligence designed to meet the specific needs of diverse industries and markets.
1000
+Commodities
150
+Countries Covered
3000
+Clients
20
+Industry
Robust Methodologies & Extensive Resources
IMARC delivers precise commodity pricing insights using proven methodologies and a wealth of data to support strategic decision-making.
Subscription-Based Databases
Our extensive databases provide detailed commodity pricing, import-export trade statistics, and shipment-level tracking for comprehensive market analysis.
Primary Research-Driven Insights
Through direct supplier surveys and expert interviews, we gather real-time market data to enhance pricing accuracy and trend forecasting.
Extensive Secondary Research
We analyze industry reports, trade publications, and market studies to offer tailored intelligence and actionable commodity market insights.
Trusted by 3000+ industry leaders worldwide to drive data-backed decisions. From global manufacturers to government agencies, our clients rely on us for accurate pricing, deep market intelligence, and forward-looking insights.